Miltenyi Biotec
Miltenyi Biotec is a global biotechnology company that develops and manufactures products and services for cell separation, cell therapy, flow cytometry, and related research and clinical applications. It serves academic and industrial researchers, biopharmaceutical companies, and clinical institutions with instruments, reagents, and contract services that support basic research, drug development, and cell and gene therapy manufacturing. Revenue is generated primarily through the sale of lab equipment and consumables, as well as specialized services and solutions for cell processing and analysis.
- Revenue
- $250M - $1B
- Employees
- 1,001 - 5,000
- Founded
- 1989
- Headquarters
- Bergisch Gladbach, Germany
Miltenyi Biotec customers on Arbolus
Customers who reviewed Miltenyi Biotec
Seniority of Miltenyi Biotec customers
The largest group of people who reviewed Miltenyi Biotec holds Director roles (50%), followed by Manager (25%) and C-Suite (25%).
- Director 50%
- Manager 25%
- C-Suite 25%
Customers sample
Employer names and spend open in the full report, along with the other 10 customers.
What 13 Arbolus experts think of Miltenyi Biotec
Overall sentiment: Positive
NPS distribution shows 61.5% Promoters, 23.1% Passives, and 15.4% Detractors, with an NPS score of 46.2 and an average NPS of 8.23. Renewal intent is strong, with 75% of respondents indicating they would renew. Stickiness is high, as 76.9% of users have been with the platform for more than one year. Key expert feedback highlights automation, reliability, and regulatory compliance as strengths, while vendor lock-in and supply chain risks are noted as weaknesses.
Everything 13 customers told us about Miltenyi Biotec.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
46 Net Promoter Score, from 13 scored reviews- Promoters 8
- Passives 3
- Detractors 2
Praised
- AI-Driven Process Optimization
- Automation and Closed-System Reliability
Criticised
- Proprietary Ecosystem and Supply Chain Risk
- Competitive Threat from Open Systems
What Miltenyi Biotec customers say
Automation and Closed-System Reliability
“I would recommend Miltenyi because their system allows you to take a complex cell therapy out of a massive cleanroom and into a highly controlled, automated, factory-in-a-box.”
AI-Driven Process Optimization
“If an enterprise AI model could dynamically monitor cell metabolic data and autonomously adjust operating parameters, we could drastically improve batch yields without manual process engineering.”
Proprietary Ecosystem and Supply Chain Risk
“The primary gap with Miltenyi is their strict walled garden ecosystem, which creates extreme supply chain vulnerability if there is a backorder on a specific consumable.”
Renewal intent
Plan to renew 80%Plan to renew, by seniority
- 100% 1 answer
- 100% 2 answers
- 50% 2 answers
- 8.8/10 Average score from customers who will renew
- 6/10 Average score from undecided customers
Report
For people who use Miltenyi Biotec
Do you use Miltenyi Biotec at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 13 customers of Miltenyi Biotec have already contributed
Takes a few minutes. Your identity stays anonymous.